Navigation Links
St. Francis Hospital to be Part of Major Nationwide Study Using a Catheter-Based Aortic Valve Replacement
Date:1/11/2011

iologist.  Nothing that I have witnessed in the past can change the way we practice interventional cardiology in such a dramatic way," says Dr. Petrossian.

"CoreValve has been used extensively in Europe.  The expectation is that we will be able to treat patients that otherwise we could not have treated, and be able to improve their lifestyles so they can stay out of heart failure for a longer period of time even though they aren't a candidate for surgery," says Dr. Robinson.

The Hospital's Chairman of Cardiology, Richard Shlofmitz, M.D., was instrumental in bringing the study to St. Francis.  He sees a time in the future when the benefits of these innovative devices will be available to a broader segment of patients who are not a high risk for surgery.  "This new approach is likely to have the same impact on the treatment of valvular disease as stenting did on coronary artery disease."

For more information about the study, log on to www.clinicaltrials.gov.  For more information about enrolling in the study, call (516) 562-6790, or visit www.stfrancisheartcenter.com.

Contact: Paul Barry, 516-705-6657, paul.barry@chsli.org

Rosemary Gomez, 516-705-6656, rosemary.gomez@chsli.org

(i) Iung B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J. 2003;26:2714-2720.


'/>"/>
SOURCE St. Francis Hospital
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial
2. TargeGen Affiliates Scheduled for Oral Presentation of Interim Clinical Trial Data at 2008 ASH Meeting in San Francisco for TG101348, a Potent, Selective, Oral JAK2 Inhibitor in Myeloproliferative Disease Patients
3. Antheras Varespladib Meets Primary Endpoint in Phase 2 FRANCIS Trial for the Treatment of Acute Coronary Syndrome
4. St. Francis Surgeon Uses Tissue Regeneration Technology to Rebuild Patients Heart Structures
5. Marc J. Fagel of the U.S. Securities and Exchange Commission to Discuss SEC Enforcement at CBIs Biotech/Pharma Finance and Accounting Forum in San Francisco
6. Takeda San Francisco, Inc. Appoints Michael Buckley, Ph.D. Vice President of Process Sciences
7. Oramed Pharmaceuticals was Chosen to Present Results of a GLP-1 Analog Oral Administration Study at the Diabetes Technology Societys Ninth Annual Meeting (November 5-7, 2009; San Francisco, CA)
8. Lumenis Introduces Advanced Retinal Laser Delivery Technology at the 2009 American Academy of Ophthalmology Annual Meeting in San Francisco, California, USA
9. Spherix to Present at Annual OneMedPlace Finance Forum and at EBD Biotech Showcase in San Francisco
10. Dehaier Medical Systems to Present to Investors at Global Hunter Securities 2010 China Investor Conference in San Francisco
11. BIO Ventures for Global Health Opens San Francisco Office; Hires New Senior Staff
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Mass., May 6, 2015 NxStage Medical, Inc. (Nasdaq: ... products, today reported first quarter financial results that exceed ... Revenue for the first quarter of 2015 increased ... $72.2 million for the first quarter of 2014. The ... $77.5 million to $78.5 million.  The increase was driven ...
(Date:5/6/2015)... 2015  Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ) ... and commercialization of a once-daily, oral therapy for the ... that it will host a conference call and webcast ... the period ended March 31, 2015 and to provide ... clinical program for aramchol. Conference Call ...
(Date:5/6/2015)... 6, 2015   Sigma-Aldrich Corporation (NASDAQ: SIAL ... today announced a $50,000 product donation to the ... replicate key findings from recent high-impact papers in the ... between the online research marketplace Science Exchange , ... the open-access journal eLife. The goal of ...
Breaking Medicine Technology:NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 2NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 3NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 4NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 5NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 6NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 7NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 8NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 9NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 10NxStage Reports First Quarter 2015 Financial Results And Exceeds Guidance 11Galmed Pharmaceuticals First Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, May 13, 2015 2Galmed Pharmaceuticals First Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, May 13, 2015 3Sigma-Aldrich Donates $50K in Products to the Reproducibility Project to Foster Replicable Research and Accelerate Scientific Discoveries in Cancer Biology 2Sigma-Aldrich Donates $50K in Products to the Reproducibility Project to Foster Replicable Research and Accelerate Scientific Discoveries in Cancer Biology 3
... the American,Society of Hematology (ASH) and the American ... joint guideline on the use of,erythropoiesis-stimulating agents (ESAs), ... to produce more red blood cells, to treat,chemotherapy-related ... to inform clinicians with the most,up-to-date evidence from ...
... and efficacy of TAXUS drug- ... stent compared to bare-metal stent, NATICK, Mass., and WASHINGTON, ... announced five-year and final,follow- up data from its TAXUS IV ... -- in patients who received a TAXUS(R),Express(TM) Paclitaxel-Eluting Coronary Stent ...
Cached Medicine Technology:ASCO and ASH Release Updated Guideline on the Use of Chemotherapy-Related Anemia Treatments in Cancer Patients 2ASCO and ASH Release Updated Guideline on the Use of Chemotherapy-Related Anemia Treatments in Cancer Patients 3Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial 2Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial 3Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial 4
(Date:5/6/2015)... Anitha Nallari, MD has joined Shakir ... in Columbus, OH. Dr. Nallari will see patients with ... breast cancer, lung cancer, GI and gallbladder cancer, head and ... hematology. , Dr. Anitha Nallari is Board Certified ... Board of Internal Medicine. She completed her medical education in ...
(Date:5/6/2015)... Anitoa Systems, (“Anitoa”), a Palo Alto startup ... China, has successfully demonstrated a handheld real time quantitative-polymerase-chain-reaction ... Anitoa’s handheld qPCR is shown to be capable of ... hepatitis B, C, and E. Coli. This qPCR system ... and over 9 orders of magnitude dynamic range. ...
(Date:5/6/2015)... The 2015 STEMtech conference exhibition hall ... booth selection . Don’t miss this opportunity to ... and university decision-makers from around the country. , This ... the Arizona Grand in Phoenix. This beautiful all-suite hotel ... doorstep of the South Mountain Preserve. The Phoenix area ...
(Date:5/6/2015)... Los Angeles, California (PRWEB) May 06, 2015 ... has secured its first round of VC funding and ... , The enterprise class embeddable software enables applications ... transform data as it moves between systems and locations. ... the HyperTransfer technology moves files at line speed, independent ...
(Date:5/6/2015)... New york, NY (PRWEB) May 06, 2015 ... on strategy, design, creative and technology, announced today that ... an expert advisor by Shocase, a marketing professional network ... the marketing sector. , Widely regarded as a specialist ... of the most high-profile branding programs over the last ...
Breaking Medicine News(10 mins):Health News:New Oncologist to Join Hematology Oncology Consultants, Inc. 2Health News:New Oncologist to Join Hematology Oncology Consultants, Inc. 3Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 3Health News:STEMtech Conference Exhibitors Gain Access to Community College and University Representatives From Across the U.S. 2Health News:TransferSoft Launches Industry’s Most Comprehensive Data Movement Technology Suite to Optimize Disaster Recovery, Big Data, and Cloud Applications 2Health News:TransferSoft Launches Industry’s Most Comprehensive Data Movement Technology Suite to Optimize Disaster Recovery, Big Data, and Cloud Applications 3Health News:TransferSoft Launches Industry’s Most Comprehensive Data Movement Technology Suite to Optimize Disaster Recovery, Big Data, and Cloud Applications 4Health News:Shocase Selects MBLM’s Claude Salzberger as Company Advisor 2
... survival of cells that are exposed to stress. Researchers at ... operation some time ago but now Hsp90 has surprised ... results are published in the current online issue of the ... cancer medication. Proteins are the motors of the cell: ...
... Playing "media detective" allows children to understand the intentions of ... resist messages that encourage alcohol or tobacco use. ... shows that teaching children as early as third grade to ... use. The study, based on the research of Erica Weintraub ...
... Steven Reinberg HealthDay Reporter , MONDAY, Aug. 23 ... potentially tainted by salmonella, the head of the U.S. Food ... additional sort of sub-recalls over the next couple of days, ... distribution of these eggs that are contaminated," agency director Margaret ...
... at math in school, so that,s what she pursued as a ... Houston, Texas, and met some cardiologists at a party, she started ... them. "I realized we could provide them with a fluid ... about, for example, which stent grafts they use in their procedures," ...
... flooding of New Orleans caused the evacuation of 1.5 ... remained displaced, many residing in highly transitional shelters, including ... mark, substantial consequences from this prolonged displacement have resulted ... the region, according to a new study by the ...
... Although the medical community has already accepted that colorectal ... researchers have found that computed tomography colonography (CTC or ... the yield of identifying significant early extracolonic (outside the ... study in the September issue of the American Journal ...
Cached Medicine News:Health News:Munich researchers demonstrate rocking movement in the anti-stress protein Hsp90 2Health News:'Media detective' tool empowers children to skirt alcohol and tobacco marketing messages 2Health News:FDA Chief Says More Egg Recalls Possible 2Health News:FDA Chief Says More Egg Recalls Possible 3Health News:FDA Chief Says More Egg Recalls Possible 4Health News:Math from the heart: Simulating stent design and coating 2Health News:Math from the heart: Simulating stent design and coating 3Health News:'Legacy of Katrina' report details impact of stalled recovery on mental health status of children 2Health News:'Legacy of Katrina' report details impact of stalled recovery on mental health status of children 3Health News:'Legacy of Katrina' report details impact of stalled recovery on mental health status of children 4
... The Uniflex Humeral Nail System has been ... in which noninvasive treatments have historically failed ... a unique blend of strength and flexibility. ... strength of titanium alloy is twice that ...
... Building on a strong heritage, the ... a new standard in ophthalmic ultrasound instrumentation. ... options, OcuScan RxP makes it simple to ... reproducible. Designed to enhance patient care by ...
... The AIM Titanium Tibial ... address the mechanical failures of ... indications for tibial interlocking nails. ... full range of diameters and ...
Arthroscopic instrument system for instability and SLAP fixation....
Medicine Products: